Drug used in breast and ovarian cancer could lead to safer, more effective treatment for neuroblasto

A type of drug known as a PARP inhibitor, already used to treat breast and ovarian cancer, may be useful in treating children with high-risk neuroblastoma—a common childhood tumor with a low survival rate.